This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicinalProductDefinition.
Generated Narrative
Id: example
Identifier: {mpid}
Classification: ATC: B01AF02
Attached Document: (SmPC)
Master File: (Pharmacovigilence Master File)
Product Name: Equilidem 2.5 mg film-coated tablets
Name Part
part:Equilidem
type: Invented
Name Part
part:2.5 mg
type: Strength
Name Part
part:film-coated tablets
type: Form
Country & Languages
- Country Jurisdiction Language * EU EU EN
Manufacturing & Business Operations
- | Type | EffectiveDate | Authorization |
* | Batch Release | 2013-03-15 --> (ongoing) | 1324TZ |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.